Net Cash Provided by (Used in) Financing Activities of BIO-TECHNE Corp from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIO-TECHNE Corp quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIO-TECHNE Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $44,204,000, a 282% decline year-over-year.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $253,905,000, a 107% decline from 2024.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $122,398,000, a 641% decline from 2023.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22,616,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $44,204,000 -$32,633,000 -282% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q3 2024 $11,571,000 -$83,083,000 -116% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2026 Q1
Q3 2023 $71,512,000 +$103,318,000 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2025 Q1
Q3 2022 $31,806,000 +$7,878,000 +20% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2024 Q1
Q3 2021 $39,684,000 -$4,751,000 -14% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2023 Q1
Q3 2020 $34,933,000 -$10,664,000 -44% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2022 Q1
Q3 2019 $24,269,000 -$246,800,000 -111% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q3 2018 $222,531,000 +$273,485,000 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2020 Q1
Q3 2017 $50,954,000 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2019 Q1
Q3 2013 $9,902,000 +$846,000 +7.9% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q3 2012 $10,748,000 +$10,808,000 +50% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2014 Q1
Q3 2011 $21,556,000 -$10,643,000 -98% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2013 Q1
Q3 2010 $10,913,000 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011 2012 Q1

BIO-TECHNE Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $253,905,000 -$131,507,000 -107% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025 2025 FY
2024 $122,398,000 -$145,014,000 -641% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025 2025 FY
2023 $22,616,000 +$265,469,000 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025 2025 FY
2022 $242,853,000 -$180,302,000 -288% 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024 2024 FY
2021 $62,551,000 +$121,251,000 +66% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023 2023 FY
2020 $183,802,000 -$318,186,000 -237% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022 2022 FY
2019 $134,384,000 +$233,572,000 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021 2021 FY
2018 $99,188,000 -$288,301,000 -152% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020 2020 FY
2017 $189,113,000 +$212,483,000 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
2016 $23,370,000 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018 2018 FY
2013 $44,677,000 +$19,948,000 +31% 01 Jul 2012 30 Jun 2013 10-K 29 Aug 2013 2013 FY
2012 $64,625,000 -$28,337,000 -78% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2013 2013 FY
2011 $36,288,000 +$14,223,000 +28% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013 2013 FY
2010 $50,511,000 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.